21 May 2013
Keywords: corvas, completes, ph, ia, napc2, completed, phase
Article | 09 October 1997
- Corvas has completed a Phase Ia trial of its anticoagulant,recombinant NAPc2. When administered to healthy male volunteers at doses
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 1997
8 October 1997
20 May 2013
© 2013 thepharmaletter.com